Pratit

Interventional and vascular neurologist @capitalhealthnj and @CooperHospital.

[Pratit @PratitDPatel]

Equip yourself with knowledge of ARIA, that we are likely to encounter in upcoming years! #ISC2024

[Pratit @PratitDPatel]

One of the popular sessions from last year, scheduled again tomorrow at 9:15 am MST. #ISC2024

[NeuroNews @NN_publishing]

.@almuftifawaz and @PratitDPatel have just introduced an #ISC24 session including several late-breaking oral abstract presentations - the first of which sees @oozaidat deliver one-year follow-up results from the @TESLATrial
#ISC2024

[Pratit @PratitDPatel]

“Large core is number one excuse for not treating LVO, and should no longer be”— Dr. Tudor Jovin

@CooperNeuroRes @CooperNeuroInt @TudorGJovin

[Pratit @PratitDPatel]

Fantastic talk on Economic Efficiency in enabling stroke thomnectomy by @ShashvatDesai at ESOC 2023 in Munich 🇩🇪

@HonorHealth @BarrowNeuro @ESOstroke @AshuPJadhav @dyavagal @KunakornAt @GravityMedTech @TudorGJovin @Mouhammad_Jumaa @MThrombectomy @CerebrovascLab

[Pratit @PratitDPatel]

After 5 years, ARCADIA interim analysis showed no evidence for empiric anticoagulation after ESUS, even in patients with atrial cardiopathy! Pending secondary analysis

#ESOC2023 @ShashvatDesai @JimSiegler @Matt_StarrMD @AshuPJadhav @AshuPJadhav @TudorGJovin

[Shashvat M. Desai @ShashvatDesai]

ELAN trial (early vs. delayed initiation of DOACs for post ischemic stroke pts)

@AshuPJadhav @KunakornAt @TudorGJovin @ShahidNimjee @dyavagal @PratitDPatel @ESOstroke
@HRInstitute_AZ @BarrowNeuro @YoungNIR

Results- attached in pics

[Shashvat M. Desai @ShashvatDesai]

The most comprehensive & current review of "Direct to Angio" for stroke @ShashvatDesai @AshuPJadhav @TudorGJovin @MPeyT1 #PoojaKhatri @HRInstitute_AZ @BarrowNeuro @CooperNeuroRes @uc_health @UniBasel_en https://t.co/0HF8tVllRG

[Pratit @PratitDPatel]

@hamzashaikhmd @CooperHealthNJ @cooper That’s bit generous of title.. ballast for bigger systems and benchmark for smaller systems in DeVO

[Tudor G. Jovin, MD @TudorGJovin]

Another win for the democratization of thrombectomy. MR CLEAN late results just presented at @WorldStrokeOrg meeting showed benefit of EVT within 6-24 hrs when patients are selected based on presence of collaterals on CTA, rendering CTP, MRI & perfusion software non-essential.

[Cooper Neurology Residency @CooperNeuroRes]

3/ …and debates by our outstanding clinician leaders

***Direct to CSC for thrombectomy vs PSC first***
@ThonJesse vs. @JimSiegler

***Thrombolysis before thrombectomy?***
@TudorGJovin vs. @PratitDPatel

[Pratit @PratitDPatel]

@neuroangio1 @Kittijack1 RIP.. truely a huge loss

[Capital Health @capitalhealthnj]

ICYMI: Dr. Pratit Patel, a board certified interventional neurologist at the Capital Institute for Neurosciences, discusses some important things to know about brain aneurysms, including symptoms, causes, risk factors, treatments and more. Watch here ⬇️

https://t.co/eFdh2YPIrL

[Cooper Neurology Residency @CooperNeuroRes]

Our chair and fearless leader @TudorGJovin concluding the day of the #stroke symposium by debating stenting versus endarterectomy for carotid disease.

Thank you to all the speakers and guests for making this program such a success!

[YoungNIR @YoungNIR]

🗓 Don't miss @AANMember “Stroke/Vascular Neurology Section Meeting" at 2PM CST MAY 24

Section Chair @AshuPJadhav
TOPICS TO BE DISCUSSED
✅Converting from TPA➡️TNK
🚑Mobile Stroke Units
📺Telestroke
🔺Clinical Trial Enrollment

Register HERE➡
https://t.co/Ytrh39utEU

[Tudor G. Jovin, MD @TudorGJovin]

Timely publication of our paper during times of national contrast media shortage !!
In the early time window, CTP based selection for thrombectomy does not yield better clinical outcomes or stronger benefit over medical therapy alone compared with no CTP. https://t.co/txyQ2AjVxG

[Tudor G. Jovin, MD @TudorGJovin]

Honored to present results of #BAOCHE on behalf of BAOCHE investigators @ESOC’22 today. 212 BA occlusion pts, randomized within 6-24 to Solitaire AB vs BMT. No large core on CT/MRI.
EVT beneficial w NNT of 4.5. We now have evidence supporting EVT for BA occlusion up to 24 hrs !!

[NeuroNews @NN_publishing]

The final clinical trial presentation at this year's @ESOstroke conference sees @TudorGJovin deliver results from the BAOCHE study. These results are similar to those from ATTENTION and further support #EVT use in basilar artery occlusion, he notes #ESOC2022 @ESOstroke

[AshuJadhav @AshuPJadhav]

Stroke: Vascular and
Interventional Neurology https://t.co/ylXDRufDud

[Gabor Toth, MD @GaborTothMD]

Join @almuftifawaz and myself moderating the 2022 @AANMember-@svinsociety joint mentoring session on Monday April 25 at 4 pm EST with speakers: @Robin_Novakovic @NguyenThanhMD @AmeerEHassan @dyavagal @AshuPJadhav @SantiagoOrtegaMD Register at: https://t.co/QRk5hE9CWs